Brain cancer survivor develops a platform designed to personalize treatment and improve outcomes for brain tumor patients.
The screen worked, flagging expected cancer genes. But it also kept returning something that seemed impossible: genes for synapses, glutamate receptors, and neural signaling pathways. “We absolutely ...